Published in J Clin Oncol on June 01, 1999
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg (2005) 1.45
New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer (2008) 1.45
Axillary lymph nodes in breast cancer patients: sonographic evaluation. Radiol Bras (2015) 1.24
Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg (2003) 1.19
Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg (2005) 1.14
Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol (2002) 1.11
Axillary staging of breast cancer and the sentinel node. J Clin Pathol (2000) 1.08
Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg (2004) 0.96
Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. J Clin Pathol (2002) 0.95
Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol (2002) 0.94
Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes. PLoS One (2012) 0.92
Efficiency of ultrasound and ultrasound-guided fine needle aspiration cytology in preoperative assessment of axillary lymph node metastases in breast cancer. J Breast Cancer (2012) 0.90
Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy. Int J Clin Oncol (2008) 0.89
Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla. World J Surg (2012) 0.88
Sentinel node detection in pre-operative axillary staging. Eur J Nucl Med Mol Imaging (2004) 0.88
Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer. Br J Cancer (2012) 0.88
Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg (2004) 0.87
Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol (2004) 0.86
Recent advances in the surgical care of breast cancer patients. World J Surg Oncol (2010) 0.86
Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast. Am J Pathol (2000) 0.85
Early breast cancer. Int J Clin Oncol (2006) 0.84
Breast cancer: Actual methods of treatment and future trends. Rep Pract Oncol Radiother (2014) 0.84
Which patients need an axillary clearance after sentinel node biopsy? Int J Breast Cancer (2011) 0.82
Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node. Proc (Bayl Univ Med Cent) (2003) 0.81
Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method. J Exp Clin Cancer Res (2015) 0.81
Survival analysis following sentinel lymph node biopsy: a validation trial demonstrating its accuracy in staging early breast cancer. Proc (Bayl Univ Med Cent) (2005) 0.81
Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer. Can J Surg (2009) 0.80
Efficiency of a preoperative axillary ultrasound and fine-needle aspiration cytology to detect patients with extensive axillary lymph node involvement. PLoS One (2014) 0.80
Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer. Surg Today (2006) 0.80
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer (2008) 0.79
Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg (2005) 0.79
Classification of Metastatic versus Non-Metastatic Axillary Nodes in Breast Cancer Patients: Value of Cortex-Hilum Area Ratio with Ultrasound. J Breast Cancer (2012) 0.78
Comparison of five different popular scoring systems to predict nonsentinel lymph node status in patients with metastatic sentinel lymph nodes: a tertiary care center experience. Springerplus (2015) 0.77
Sentinel lymph node mapping in early breast cancer - Our experience. Indian J Surg Oncol (2010) 0.77
Validation of online calculators to predict the non-sentinel lymph node status in sentinel lymph node-positive breast cancer patients. Surg Today (2012) 0.77
Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial. Eur Arch Otorhinolaryngol (2014) 0.76
Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch (2005) 0.75
Value of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma. Indian J Surg Oncol (2010) 0.75
Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Indian J Surg Oncol (2010) 0.75
Is Completion Axillary Dissection Necessary for This Patient? J Breast Health (2013) (2014) 0.75
Subtype is a predictive factor of nonsentinel lymph node involvement in sentinel node-positive breast cancer patients. J Breast Cancer (2014) 0.75
Sentinel lymph node biopsy in breast cancer patients undergoing skin/nipple-sparing mastectomy and immediate autologous reconstruction. Oncol Lett (2010) 0.75
One-step nucleic acid amplification assay for intraoperative prediction of advanced axillary lymph node metastases in breast cancer patients with sentinel lymph node metastasis. Mol Clin Oncol (2015) 0.75
Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer: assessment of existent risk scores. Ann Surg Oncol (2010) 0.75
Sentinel lymph node biopsy: technique validation at the Setúbal Medical Centre, Portugal. Ecancermedicalscience (2009) 0.75
Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes. ISRN Oncol (2011) 0.75
Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis. Gland Surg (2014) 0.75
How much is enough? The continuing debate on the axillary lymph node dissection in breast cancer. Perm J (2007) 0.75
Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients. Eur J Nucl Med Mol Imaging (2005) 0.75
Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population. Indian J Surg Oncol (2015) 0.75
Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol (1995) 5.86
Nitrosopumilus maritimus genome reveals unique mechanisms for nitrification and autotrophy in globally distributed marine crenarchaea. Proc Natl Acad Sci U S A (2010) 4.12
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37
Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab (2001) 3.19
Laparoscopically assisted panenteroscopy: a feasibility study in pigs. Gastrointest Endosc (1995) 2.84
Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst (1993) 2.57
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery (2001) 2.50
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42
Outcomes after curative resections of cholangiocarcinoma. Arch Surg (1993) 2.26
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
The fate of interleukin-2 after in vivo administration. J Immunol (1983) 2.13
Breast MR imaging: interpretation model. Radiology (1997) 2.07
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06
Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 2.06
What prognostic factors are important in duodenal adenocarcinoma? Arch Surg (2000) 2.03
Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol (2012) 2.01
The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer (2001) 1.99
Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol (2000) 1.93
Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88
Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am (1997) 1.80
Characteristics of biliary tract complications during laparoscopic cholecystectomy: a multi-institutional study. Am J Surg (1994) 1.76
Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. Ann Surg Oncol (2000) 1.74
Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res (1994) 1.72
Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery (1994) 1.72
Anastomotic ulceration following subtotal and total pancreatectomy. Ann Surg (1979) 1.69
Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg (2006) 1.68
The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg (2000) 1.67
Reexploration for symptomatic hematomas after cervical exploration. Surgery (2001) 1.66
Survival after surgical treatment for primary hyperparathyroidism. Surgery (1997) 1.66
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg (2001) 1.64
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery (2000) 1.63
Spectrum and management of major complications of laparoscopic cholecystectomy. Am J Surg (1993) 1.59
Active macromolecule uptake by lymph node antigen-presenting cells: a novel mechanism in determining sentinel lymph node status. Ann Surg Oncol (2000) 1.58
Contralateral metachronous inguinal hernias in adults: role for prophylaxis during the TEP repair. Hernia (2011) 1.58
Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med (2001) 1.58
Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer (1997) 1.57
Primary thyroid lymphoma. Semin Oncol (1999) 1.57
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood (1994) 1.53
Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg (1992) 1.53
A study of metastatic cancer found during inguinal hernia repair. Cancer (1992) 1.51
Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol (1996) 1.51
Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol (2001) 1.51
Axillary web syndrome after axillary dissection. Am J Surg (2001) 1.49
Radical resection for carcinoma of the ampulla of Vater. Arch Surg (1991) 1.49
Early gastric cancer. Br J Surg (1992) 1.49
Male breast cancer. Br J Surg (1997) 1.48
Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery (1990) 1.47
Hemorrhoidal banding. A warning. Dis Colon Rectum (1985) 1.46
99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med (1999) 1.46
Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg (1990) 1.45
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res (1996) 1.44
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol (1994) 1.44
Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood (1990) 1.44
Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery (1988) 1.44
Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma. Gynecol Oncol (2000) 1.43
Incidentally discovered adrenal tumors: an institutional perspective. Surgery (1991) 1.43
Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery (1994) 1.41
Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol (2013) 1.41
Are concomitant surgical procedures acceptable in patients undergoing cervical exploration for primary hyperparathyroidism? Mayo Clin Proc (1991) 1.41
Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery (1997) 1.40
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy. Ann Oncol (1999) 1.40
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest (1995) 1.39
Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg (1996) 1.39
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience. Mayo Clin Proc (1994) 1.38
Transabdominal preperitoneal laparoscopic inguinal herniorrhaphy: assessment of initial experience. Mayo Clin Proc (1998) 1.38
Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma. Surgery (1991) 1.38
Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR Am J Roentgenol (1986) 1.37
Spectrum of US findings in pediatric and adolescent patients with palpable breast masses. Radiographics (2001) 1.36
Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med (1998) 1.36
Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery (1998) 1.35
Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer (2001) 1.35
Is calciphylaxis best treated surgically or medically? Surgery (2000) 1.33
Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery (2000) 1.32
Obturator hernia: the Mayo Clinic experience. Hernia (2011) 1.30
Biliary tract complications of laparoscopic cholecystectomy are detected more frequently with routine intraoperative cholangiography. Surg Endosc (1995) 1.30
Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer. Lasers Surg Med (2006) 1.29
Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg (1990) 1.29
Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol (1987) 1.27
Molecular markers in male breast carcinoma. Cancer (1998) 1.26
Primary ovarian carcinoid tumors. Gynecol Oncol (1996) 1.26
Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg (2002) 1.26